Insider Trading activities of Clovis Oncology, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Clovis Oncology, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Clovis Oncology, Inc. since year 2005. Table 2 shows the detailed insider transactions of Clovis Oncology, Inc. since 2005. The reporting company's ticker symbol is CLVS. The reporting company's CIK number is 1466301.
The total value of stock buying since 2005 is $297,885,590.
The total value of stock sales since 2005 is $46,480,578.
The total value of stock option exercises since 2005 is $1,119,400.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Clovis Oncology, Inc. (CLVS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 0 $0 4,500 $270,000 0 $0
2017-11 0 $0 3,000 $191,100 1,415 $0
2017-10 0 $0 3,000 $253,620 0 $0
2017-09 0 $0 3,000 $208,500 0 $0
2017-08 0 $0 21,450 $1,660,504 5,663 $0
2017-07 0 $0 3,000 $274,680 0 $0
2017-06 0 $0 3,000 $185,460 0 $0
2017-05 0 $0 3,000 $142,170 0 $0
2017-04 0 $0 3,000 $168,060 0 $0
2017-03 0 $0 3,000 $200,969 1,250 $0
2015-11 0 $0 3,000 $312,543 0 $0
2015-10 0 $0 14,000 $1,314,142 8,000 $24,640
2015-09 0 $0 6,000 $574,938 0 $0
2015-08 0 $0 3,000 $258,369 0 $0
2015-07 0 $0 3,000 $259,761 0 $0
2015-06 0 $0 3,000 $266,064 0 $0
2015-05 0 $0 9,733 $836,549 0 $0
2015-04 0 $0 3,000 $216,786 0 $0
2015-03 0 $0 37,528 $2,978,827 20,000 $220,400
2015-02 0 $0 10,000 $720,000 10,000 $110,200
2015-01 0 $0 100,000 $6,535,588 20,000 $220,400
2014-05 0 $0 0 $0 24,827 $378,363
2013-12 0 $0 59,000 $3,161,838 0 $0
2013-06 0 $0 199,827 $13,089,616 10,000 $110,200
2013-03 0 $0 504,200 $12,400,494 0 $0
2012-12 0 $0 0 $0 32,758 $55,197
2012-08 9,701 $150,405 0 $0 0 $0
2012-04 25,000 $500,000 0 $0 0 $0
2011-11 24,195,221 $297,235,185 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Clovis Oncology, Inc. insiders (CLVS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-08 Spickschen Thorlef (Director) Sale 4,500 60.00 270,000
2017-11-29 Hooks Corwin Dale (See Remarks) Option Ex 868 .00 0
2017-11-29 Muehl Daniel W (See Remarks) Option Ex 547 .00 0
2017-11-15 Ivers-read Gillian C (See Remarks) Sale 3,000 63.70 191,100
2017-10-16 Ivers-read Gillian C (See Remarks) Sale 3,000 84.54 253,620
2017-09-15 Ivers-read Gillian C (See Remarks) Sale 3,000 69.50 208,500
2017-08-25 Hooks Corwin Dale (See Remarks) Option Ex 3,475 .00 0
2017-08-25 Muehl Daniel W (See Remarks) Option Ex 2,188 .00 0
2017-08-15 Ivers-read Gillian C (See Remarks) Sale 3,000 70.05 210,150
2017-08-04 Blair James C (Director) Sale 18,450 78.61 1,450,354
2017-07-17 Ivers-read Gillian C (See Remarks) Sale 3,000 91.56 274,680
2017-06-15 Ivers-read Gillian C (See Remarks) Sale 3,000 61.82 185,460
2017-05-15 Ivers-read Gillian C (See Remarks) Sale 3,000 47.39 142,170
2017-04-17 Ivers-read Gillian C (See Remarks) Sale 3,000 56.02 168,060
2017-03-15 Ivers-read Gillian C (See Remarks) Sale 3,000 66.99 200,969
2017-03-08 Muehl Daniel W (See Remarks) Option Ex 1,250 .00 0
2015-11-02 Mast Erle T (Executive VP and CFO) Sale 3,000 104.18 312,543
2015-10-28 Rolfe Lindsey (See Remarks) Sale 4,000 97.80 391,216
2015-10-28 Rolfe Lindsey (See Remarks) Option Ex 4,000 3.08 12,320
2015-10-15 Ivers-read Gillian C (See Remarks) Sale 3,000 91.91 275,730
2015-10-05 Rolfe Lindsey (See Remarks) Sale 4,000 93.72 374,892
2015-10-05 Rolfe Lindsey (See Remarks) Option Ex 4,000 3.08 12,320
2015-10-01 Mast Erle T (Executive VP and CFO) Sale 3,000 90.77 272,304
2015-09-18 Ivers-read Gillian C (See Remarks) Sale 3,000 112.56 337,680
2015-09-01 Mast Erle T (Executive VP and CFO) Sale 3,000 79.09 237,258
2015-08-03 Mast Erle T (Executive VP and CFO) Sale 3,000 86.12 258,369
2015-07-01 Mast Erle T (Executive VP and CFO) Sale 3,000 86.59 259,761
2015-06-01 Mast Erle T (Executive VP and CFO) Sale 3,000 88.69 266,064
2015-05-15 Barrett M James (Director) Sale 2,424 92.22 223,536
2015-05-13 Spickschen Thorlef (Director) Sale 4,309 85.00 366,269
2015-05-01 Mast Erle T (Executive VP and CFO) Sale 3,000 82.25 246,744
2015-04-01 Mast Erle T (Executive VP and CFO) Sale 3,000 72.26 216,786
2015-03-09 Mast Erle T (Executive VP and CFO) Sale 9,000 79.58 716,202
2015-03-05 Hoerter Steven L. (See Remarks) Sale 20,000 80.00 1,600,000
2015-03-05 Hoerter Steven L. (See Remarks) Option Ex 20,000 11.02 220,400
2015-03-05 Blair James C (Director) Sale 8,528 77.70 662,625
2015-02-17 Hoerter Steven L. (See Remarks) Sale 10,000 72.00 720,000
2015-02-17 Hoerter Steven L. (See Remarks) Option Ex 10,000 11.02 110,200
2015-01-16 Hoerter Steven L. (See Remarks) Sale 10,000 67.00 670,000
2015-01-16 Hoerter Steven L. (See Remarks) Option Ex 10,000 11.02 110,200
2015-01-16 Allen Andrew R (See Remarks) Sale 79,700 65.57 5,226,088
2015-01-15 Allen Andrew R (See Remarks) Sale 300 65.00 19,500
2015-01-13 Hoerter Steven L. (See Remarks) Sale 10,000 62.00 620,000
2015-01-13 Hoerter Steven L. (See Remarks) Option Ex 10,000 11.02 110,200
2014-05-14 Mckinley Edward J (Director) Option Ex 24,827 15.24 378,363
2013-12-11 Mast Erle T (Executive VP and CFO) Sale 24,123 52.01 1,254,637
2013-12-10 Mast Erle T (Executive VP and CFO) Sale 25,877 54.19 1,402,274
2013-12-05 Spickschen Thorlef (Director) Sale 6,000 55.97 335,790
2013-12-04 Spickschen Thorlef (Director) Sale 3,000 56.38 169,137
2013-06-05 Allen Andrew R (See Remarks) Sale 22,594 68.32 1,543,667
2013-06-04 Hoerter Steven L. (See Remarks) Sale 10,000 73.06 730,600
2013-06-04 Hoerter Steven L. (See Remarks) Option Ex 10,000 11.02 110,200
2013-06-04 Barrett M James (Director) Sale 2,483 70.80 175,796
2013-06-04 Schoemaker Kathleen K (10% Owner) Sale 161,971 64.58 10,460,086
2013-03-06 Schoemaker Kathleen K (10% Owner) Sale 100,000 24.51 2,450,999
2013-03-05 Schoemaker Kathleen K (10% Owner) Sale 129,000 24.69 3,185,009
2013-03-04 Schoemaker Kathleen K (10% Owner) Sale 25,200 24.44 615,887
2012-12-27 Mckinley Edward J (Director) Option Ex 32,758 1.69 55,197
2012-08-16 Mckinley Edward J (Director) Buy 3,500 15.66 54,810
2012-08-15 Mckinley Edward J (Director) Buy 1,000 15.50 15,500
2012-08-14 Mckinley Edward J (Director) Buy 5,201 15.40 80,095
2012-04-10 Mckinley Edward J (Director) Buy 25,000 20.00 500,000
2011-11-21 Viswanathan Ravi (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Nea Partners 13, Limited Partnership (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Allen Andrew R (See Remarks) Buy 3,846 13.00 49,998
2011-11-21 Domain Parters Vii L P (10% Owner) Buy 916,058 13.00 11,908,754
2011-11-21 Dp Vii Associates Lp (10% Owner) Buy 15,625 13.00 203,125
2011-11-21 Weller Harry R (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Halak Brian K (10% Owner) Buy 931,683 13.00 12,111,879
2011-11-21 Mckinley Edward J (Director) Buy 79,857 13.00 1,038,141
2011-11-21 Drant Ryan D (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Baskett Forest (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Kolluri Krishna Kittu (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Spickschen Thorlef (Director) Buy 13,309 13.00 173,017
2011-11-21 Ivers-read Gillian C (See Remarks) Buy 5,323 13.00 69,199
2011-11-21 Mahaffy Patrick J (President and CEO) Buy 39,927 13.00 519,051
2011-11-21 Sandell Scott D (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Kerins Patrick J (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Mott David M (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Barrett M James (Director) Buy 1,316,299 13.00 17,111,887
2011-11-21 Schoemaker Kathleen K (10% Owner) Buy 931,683 13.00 12,111,879
2011-11-21 Dovey Brian H (10% Owner) Buy 931,683 13.00 12,111,879
2011-11-21 Vitullo Nicole (10% Owner) Buy 931,683 13.00 12,111,879
2011-11-21 Mast Erle T (Executive VP and CFO) Buy 5,323 13.00 69,199
2011-11-21 Blair James C (Director) Buy 931,683 13.00 12,111,879
2011-11-21 Treu Jesse I (10% Owner) Buy 931,683 13.00 12,111,879
2011-11-21 Barris Peter J (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Kramlich C Richard (10% Owner) Buy 1,316,299 13.00 17,111,887
2011-11-21 Klingenstein Paul H (Director) Buy 399,291 13.00 5,190,783
2011-11-16 Versant Ventures Iv, Llc (10% Owner) Buy 665,488 .00 0
2011-11-16 Atwood Brian G (Director) Buy 665,488 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of CLVS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Clovis Oncology, Inc. (symbol CLVS, CIK number 1466301) see the Securities and Exchange Commission (SEC) website.